Nasrin Motamed

1.2k total citations
44 papers, 857 citations indexed

About

Nasrin Motamed is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Nasrin Motamed has authored 44 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Pharmacology. Recurrent topics in Nasrin Motamed's work include Silymarin and Mushroom Poisoning (11 papers), Synthesis and bioactivity of alkaloids (6 papers) and Berberine and alkaloids research (5 papers). Nasrin Motamed is often cited by papers focused on Silymarin and Mushroom Poisoning (11 papers), Synthesis and bioactivity of alkaloids (6 papers) and Berberine and alkaloids research (5 papers). Nasrin Motamed collaborates with scholars based in Iran, Japan and United States. Nasrin Motamed's co-authors include Ferdous Rastgar Jazii, Setsuko Komatsu, Hamid Sobhanian, Mohammad Ali Shokrgozar, Ali Akbar Ehsanpour, Roya Razavizadeh, Yohei Nanjo, Mohammad Javad Mokhtari, Takuji Nakamura and Zohreh Jahanafrooz and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Life Sciences.

In The Last Decade

Nasrin Motamed

43 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nasrin Motamed Iran 16 427 317 160 96 87 44 857
Jayant Dewangan India 14 380 0.9× 170 0.5× 48 0.3× 41 0.4× 122 1.4× 20 768
Fangfang Zhong China 17 386 0.9× 136 0.4× 45 0.3× 51 0.5× 56 0.6× 55 680
Yoshihiro Nishikawa Japan 19 367 0.9× 196 0.6× 83 0.5× 121 1.3× 56 0.6× 95 1.0k
Shunqin Zhu China 18 599 1.4× 135 0.4× 76 0.5× 43 0.4× 201 2.3× 41 926
Ying Ye China 18 309 0.7× 156 0.5× 51 0.3× 176 1.8× 55 0.6× 27 785
Abderraouf Kénani Tunisia 20 643 1.5× 142 0.4× 55 0.3× 55 0.6× 215 2.5× 51 1.1k
Xiaojing Ma China 16 516 1.2× 125 0.4× 58 0.4× 51 0.5× 60 0.7× 38 895
Geng Zhang China 14 249 0.6× 168 0.5× 63 0.4× 84 0.9× 93 1.1× 39 638
Shenglin Zhao China 5 762 1.8× 90 0.3× 70 0.4× 95 1.0× 196 2.3× 13 1.2k
Ritu Bhalla United States 13 474 1.1× 179 0.6× 225 1.4× 33 0.3× 58 0.7× 30 726

Countries citing papers authored by Nasrin Motamed

Since Specialization
Citations

This map shows the geographic impact of Nasrin Motamed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasrin Motamed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasrin Motamed more than expected).

Fields of papers citing papers by Nasrin Motamed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasrin Motamed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasrin Motamed. The network helps show where Nasrin Motamed may publish in the future.

Co-authorship network of co-authors of Nasrin Motamed

This figure shows the co-authorship network connecting the top 25 collaborators of Nasrin Motamed. A scholar is included among the top collaborators of Nasrin Motamed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasrin Motamed. Nasrin Motamed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Delphi, Ladan, et al.. (2023). Green Tea Catechin Potentiating Doxorubicine Effects against BE(2)C Neuroblastoma Cells In Vitro. Jundishapur Journal of Natural Pharmaceutical Products. 18(1). 1 indexed citations
2.
Motamed, Nasrin, et al.. (2023). Effect of Silibinin on the Expression of Mir-20b, Bcl2L11, and Erbb2 in Breast Cancer Cell Lines. Molecular Biotechnology. 65(12). 1979–1990. 3 indexed citations
3.
Motamed, Nasrin, et al.. (2022). Carotenoids as potential inhibitors of TNFα in COVID-19 treatment. PLoS ONE. 17(12). e0276538–e0276538. 3 indexed citations
4.
Motamed, Nasrin, et al.. (2021). Semi-Solid Product of Medicinal Leech Enhances Wound Healing in Rats. Jundishapur Journal of Natural Pharmaceutical Products. 16(4). 1 indexed citations
5.
Jahanafrooz, Zohreh, Nasrin Motamed, & Behnaz Bakhshandeh. (2017). Effects of miR-21 downregulation and silibinin treatment in breast cancer cell lines. Cytotechnology. 69(4). 667–680. 18 indexed citations
6.
Mirzaei, Reza, et al.. (2016). The Safety Property of β-D-Mannuronic Acid (M2000) as a Novel Immunosuppressive Agent on Differentiation, Maturation and Function of Human Dendritic Cells. Current Drug Discovery Technologies. 13(3). 164–169. 3 indexed citations
7.
Mehrbod, Parvaneh, et al.. (2015). In Vitro Antiviral Effect of "Nanosilver" on Influenza Virus. DARU Journal of Pharmaceutical Sciences. 17(2). 88–93. 60 indexed citations
8.
Karimizadeh, Elham, Farhad Gharibdoost, Nasrin Motamed, et al.. (2015). c-Abl silencing reduced the inhibitory effects of TGF-β1 on apoptosis in systemic sclerosis dermal fibroblasts. Molecular and Cellular Biochemistry. 405(1-2). 169–176. 17 indexed citations
9.
Ebrahimi, Marzieh, et al.. (2015). Silibinin affects tumor cell growth because of reduction of stemness properties and induction of apoptosis in 2D and 3D models of MDA-MB-468. Anti-Cancer Drugs. 26(5). 487–497. 18 indexed citations
10.
Hossein‐Khannazer, Nikoo, Seyed Hassan Paylakhi, Abbas Mirshafiey, Gholamreza Azizi, & Nasrin Motamed. (2015). Silibinin, up-regulates chemokine receptor expression in MDA-MB-231 breast cancer cell line. Bangladesh Journal of Medical Science. 14(2). 190–195. 3 indexed citations
11.
Motamed, Nasrin & Zohreh Jahanafrooz. (2014). microRNA-Based Anticancer Therapies. scientific journal of ilam university of medical sciences. 22(4). 91–101. 1 indexed citations
12.
Motamed, Nasrin, et al.. (2014). The response of mouse embryonic stem cells to low doses of γ-radiation: Evidence for an adaptive response. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 761. 44–47. 10 indexed citations
13.
Karimizadeh, Elham, Nasrin Motamed, Mahdi Mahmoudi, et al.. (2014). Attenuation of fibrosis with selective inhibition of c-Abl by siRNA in systemic sclerosis dermal fibroblasts. Archives of Dermatological Research. 307(2). 135–142. 22 indexed citations
14.
Mahmoodi, Narges, et al.. (2013). Survey the Effect of Silybin on HER2 in SKBR3 Breast Cancer Cell Line. Majallah-i dānishkadah-i pizishkī. Dānishgāh-i ̒ulūm-i pizishkī-i Gīlān.. 21(84). 34–41. 2 indexed citations
15.
Motamed, Nasrin, et al.. (2012). Physiological and biochemical responses of Aeluropus lagopoides and Aeluropus littoralis to drought stress. 2(2). 5–14. 5 indexed citations
16.
Motamed, Nasrin, et al.. (2011). Genetic transformation of olive somatic embryos through Agrobacterium tumefaciens and regeneration of transgenic plants. AFRICAN JOURNAL OF BIOTECHNOLOGY. 10(28). 5468–5475. 8 indexed citations
17.
18.
Karimizadeh, Elham & Nasrin Motamed. (2010). Serial analysis of gene expression and its applications. 8(2). 2037–2042. 1 indexed citations
20.
Kamali, Fahimeh, et al.. (2009). Comparison of combined use of fluconazole and clotrimazole with the sequential dose of fluconazole in the treatment of recurrent Candida vaginitis. 12(1). 34–39. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026